(KTEN) — Researchers say they've found a new alternative to help type 1 diabetics.

The most common medicinal solution for diabetes has always been insulin injections, but a new prescription called Tzield (Teplizumab) is helping type 1 diabetics using two different drugs to further delay the onset of the disease, as well as decreasing the need for insulin injections.

Researchers said Tzield will block a step in the body's immune system to slow down any further diabetes progression. Delaying the onset of type 1 diabetes by two to five years could be helpful for pediatric diabetics.

Pottsboro pharmacist Travis Garrett said the new medication could be more efficient for patients in the long run.

"Someone in middle school to high school being able to handle the insulin therapy and the burden that that places on them having to constantly monitor your blood sugar and have insulin all the time... to push back that time of needing that insulin can be a really big difference," he said.

The Centers for Disease Control says diabetics make up nearly 11 percent of the U.S. population, about 34 million people.

Tzield is currently offered at OU Health in Norman for high-risk pediatric patients to reduce their symptoms and prevent serious diabetic complications.